Adequacy of Exsanguination Between Esmarch Bandages and Simple Leg Elevation in Total Knee Arthroplasty

Sponsor
Navamindradhiraj University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03989648
Collaborator
(none)
100
1
2
42
2.4

Study Details

Study Description

Brief Summary

To compare the adequacy of exsanguination in the surgical field between the use of the Esmarch bandages elevation and the simple leg elevation.

Condition or Disease Intervention/Treatment Phase
  • Other: Esmarch bandages
  • Other: simple leg elevation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of the Adequacy of Exsanguination Between Esmarch Bandages and Simple Leg Elevation in Minimally Invasive Total Knee Arthroplasty : A Randomized Controlled Trial
Actual Study Start Date :
Jun 1, 2019
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Esmarch bandages

Other: Esmarch bandages
Esmarch bandage (also known as Esmarch's bandage for surgical haemostasis or Esmarch's tourniquet) in its modern form is a narrow (5 to 10 cm wide) soft rubber bandage that is used to expel venous blood from a limb (exsanguinate) that has had its arterial supply cut off by a tourniquet.

Active Comparator: simple leg elevation

Other: simple leg elevation
simple leg elevation 45 degree for 2 minutes is used to expel venous blood from a limb

Outcome Measures

Primary Outcome Measures

  1. Fromme-Boezaart surgical field scale [Immediate after surgery]

    Fromme-Boezaart surgical field scale is visual assessment of surgical field using a 6-point scale (min=0, max=5) 0 mean No bleeding mean Slight bleeding ; no suctioning of blood required mean Slight bleeding ; occasional suctioning required. Surgical field not threatened mean Slight bleeding ; frequent suctioning required. Bleeding threatens surgical filed a few seconds after suction is removed mean Moderate bleeding ; frequent suctioning required. Bleeding threatens surgical field directly after suction is removed mean Severe bleeding ; constant suctioning required. Bleeding appears faster than can be removed by suction. Surgical field severely threatened and surgery not possible 0=best possible operating conditions and dryness of the surgical field; 5= worst possible conditions

Secondary Outcome Measures

  1. Numerical rating scale: NRS at 24 hrs [24 hours after surgery]

    NRS is a pain intensity assessment of patients using a 11 point scale (min=0, max=10) 0=no pain 10= worst pain

  2. Numerical rating scale: NRS at 72 hrs [72 hours after surgery]

    NRS is a pain intensity assessment of patients using a 11 point scale (min=0, max=10) 0=no pain 10= worst pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary osteoarthritis of knee
Exclusion Criteria:
  • There are deep vein thrombosis and pulmonary embolism

  • There are bleeding disorder,hypercoagulability,peripheral arterial disease and chronic venous insufficiency

  • Take blood clotting pills

  • Have had total knee arthroplasty

  • BMI > 30

Contacts and Locations

Locations

Site City State Country Postal Code
1 Navamindradhiraj University Dusit Bangkok Thailand 10300

Sponsors and Collaborators

  • Navamindradhiraj University

Investigators

  • Principal Investigator: Satit Thiengwittayaporn, M.D., Department of Orthopaedics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Satit Thiengwittayaporn, Associate Professor, Navamindradhiraj University
ClinicalTrials.gov Identifier:
NCT03989648
Other Study ID Numbers:
  • COA 028/2562
First Posted:
Jun 18, 2019
Last Update Posted:
Aug 31, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2021